Remote Cognitive Adaptation Training to improve medication follow through in managed care (R-CAT)
Remote Cognitive Adaptation Training to improve medication follow through in managed care (R-CAT)
批准号:
10209187
负责人:
Dawn Irene Velligan
金额:
$76.73万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2023-01-31
关键词:
Adaptive BehaviorsAdherenceAftercareAttentionAwarenessBehaviorBehavioralBypassChronicChronic DiseaseClinicalCognitiveConsciousCuesCustomDataDirect CostsEmergency department visitEmergency medical serviceGoalsHabitsHealthHealth PromotionHome environmentHome visitationHospital CostsHospitalizationImpairmentIndividualIntentionInterventionLeadMaintenanceManaged CareMeasuresMediationMedicalMedical Care CostsMemoryModelingMotivationOutcomePatient Self-ReportPersonsPharmaceutical PreparationsPopulationPreventionPrizeProblem SolvingProcessPublic HealthRandomizedRegimenResourcesRiskRisk FactorsRural CommunitySeriesServicesSymptomsTechnologyTelephoneTestingTextText MessagingTimeTrainingTransportationVisitWorkWorld Health Organizationbasecare costscompliance behaviorcostdesigndistractioneffectiveness testingevidence baseexperiencefollow-upforgettinghospital servicesimprovedimproved outcomeindexingmedication compliancemembermodifiable riskpillpsychosocialrepetitive behaviorresponserural settingservice utilizationsevere mental illnessstandard caresymptomatologytheoriestreatment as usualtreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Poor adherence to prescribed medications is a major public health problem across chronic illness such
as severe mental illness (SMI), leads to increased risk of hospitalizations, costs up to $300 billion annually and
is arguably one of the most important modifiable risk factors leading to poor outcomes. According to the World
Health Organization, increasing adherence may have a greater effect on health than any improvement in
specific medical treatments.
We propose to test a remotely delivered version of Cognitive Adaptation Training (R-CAT) which uses
environmental supports to bypass many of the problems people have in following through with medication even
when they think it is the right thing to do for their illness. R-CAT is designed to bypass problems including,
forgetting, distraction, problem-solving, motivation, and resources such as limited access to transportation.
CAT delivered in person has been found to improve medication follow-though, reduce hospitalizations, and
improve outcomes for individuals with SMI. R-CAT was developed to serve a larger number of individuals as
well as those in rural settings, and includes individualized medication set up; text reminders; telephone staff to
check in and assist in re-filling medication containers; mail-delivered supports (signs, customized pill
containers, alarms, checklists), limited in-home visits and a series of participation prizes to improve habit
formation and sustain good medication follow-through. We propose to randomize 266 managed care members
to R-CAT or Treatment as Usual for 6 months and to follow them for 6 months after treatment ends. Medication
follow-through will be assessed using unannounced in-home pill counts and claims data for refills. We will also
measure symptoms, service use, and care costs. In addition, we will examine the mechanisms of action of R-
CAT. The path model proposes that during treatment repetitive behavior performed at the same time, in the
same way, every day in response to R-CAT cues (i.e., taking medication because of cues, alarms, text
messages) leads to habit formation, increasing habit strength/automaticity. We propose that habit strength at
the end of treatment then predicts maintenance of adherence. Improving adherence to medication may be one
of the most important MCO-wide behavioral change targets. If successful, a remote, easy to deliver
intervention such as R-CAT in managed care has the potential to improve adherence and outcomes for those
with SMI and other chronic medical conditions and to substantially reduce the costs of care.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1093/schizbullopen/sgac062
发表时间:
2022-01
期刊:
Schizophrenia bulletin open
影响因子:
--
作者:
[]
通讯作者:
Cognitive Adaptation Training: Effectiveness in real-world settings and Mechanisms of Action (CAT-EM)
-
批准号:9769878
-
项目类别:
-
资助金额:$61.7万
-
财政年份:2018
-
负责人:Dawn Irene Velligan
-
依托单位:
Cognitive Adaptation Training: Effectiveness in real-world settings and Mechanisms of Action (CAT-EM)
-
批准号:10166942
-
项目类别:
-
资助金额:$54.65万
-
财政年份:2018
-
负责人:Dawn Irene Velligan
-
依托单位:
Cognitive Adaptation Training: Effectiveness in real-world settings and Mechanisms of Action (CAT-EM)
-
批准号:10405566
-
项目类别:
-
资助金额:$41.81万
-
财政年份:2018
-
负责人:Dawn Irene Velligan
-
依托单位:
Cognitive Adaptation Training: Effectiveness in real-world settings and Mechanisms of Action (CAT-EM)
-
批准号:9926315
-
项目类别:
-
资助金额:$54.14万
-
财政年份:2018
-
负责人:Dawn Irene Velligan
-
依托单位:
Treatment Development Targeting Severe and Persistent Negative Symptoms
-
批准号:8414843
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2011
-
负责人:Dawn Irene Velligan
-
依托单位:
Treatment Development Targeting Severe and Persistent Negative Symptoms
-
批准号:8091616
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2011
-
负责人:Dawn Irene Velligan
-
依托单位:
Treatment Development Targeting Severe and Persistent Negative Symptoms
-
批准号:8227955
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2011
-
负责人:Dawn Irene Velligan
-
依托单位:
Interventions to Improve Functional Outcome, Persistent Symptoms in Schizophrenia
-
批准号:7643872
-
项目类别:
-
资助金额:$51.25万
-
财政年份:2008
-
负责人:Dawn Irene Velligan
-
依托单位:
Intervention to Improve Functional Outcome & Persistent Symptoms in Schizophrenia
-
批准号:8250427
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2008
-
负责人:Dawn Irene Velligan
-
依托单位:
Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophre
-
批准号:8063992
-
项目类别:
-
资助金额:$50.4万
-
财政年份:2008
-
负责人:Dawn Irene Velligan
-
依托单位:
Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophre
-
批准号:7808058
-
项目类别:
-
资助金额:$51.81万
-
财政年份:2008
-
负责人:Dawn Irene Velligan
-
依托单位:
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia
-
批准号:7885345
-
项目类别:
-
资助金额:$40.53万
-
财政年份:2006
-
负责人:Dawn Irene Velligan
-
依托单位:
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia
-
批准号:7029972
-
项目类别:
-
资助金额:$44.54万
-
财政年份:2006
-
负责人:Dawn Irene Velligan
-
依托单位:
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia
-
批准号:7659479
-
项目类别:
-
资助金额:$46.88万
-
财政年份:2006
-
负责人:Dawn Irene Velligan
-
依托单位:
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia
-
批准号:7277199
-
项目类别:
-
资助金额:$46.25万
-
财政年份:2006
-
负责人:Dawn Irene Velligan
-
依托单位:
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia
-
批准号:7475698
-
项目类别:
-
资助金额:$46.35万
-
财政年份:2006
-
负责人:Dawn Irene Velligan
-
依托单位:
Compensating for Cognitive Deficits in Schizophrenia
-
批准号:6528734
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2001
-
负责人:Dawn Irene Velligan
-
依托单位:
Compensating for Cognitive Deficits in Schizophrenia
-
批准号:6790697
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2001
-
负责人:Dawn Irene Velligan
-
依托单位:
Compensating for Cognitive Deficits in Schizophrenia
-
批准号:6936592
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2001
-
负责人:Dawn Irene Velligan
-
依托单位:
Compensating for Cognitive Deficits in Schizophrenia
-
批准号:6655686
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2001
-
负责人:Dawn Irene Velligan
-
依托单位:
海外基金